Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 156 articles:
HTML format
Text format



Single Articles


    February 2019
  1. CHURCH JA, Rukobo S, Govha M, Lee B, et al
    The impact of improved water, sanitation and hygiene on oral rotavirus vaccine immunogenicity in Zimbabwean infants: sub-study of a cluster-randomized trial.
    Clin Infect Dis. 2019 Feb 16. pii: 5321771. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. WIESE AD, Huang X, Yu C, Mitchel EF, et al
    Changes in otitis media episodes and pressure equalization tube insertions among young children following introduction of the 13-valent pneumococcal conjugate vaccine: A birth-cohort based study.
    Clin Infect Dis. 2019 Feb 16. pii: 5321113. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. NEUZIL KM, Pollard AJ, Marfin AA
    Introduction of Typhoid Conjugate Vaccines in Africa and Asia.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  4. KARIUKI S, Mbae C, Onsare R, Kavai SM, et al
    Multidrug-resistant Nontyphoidal Salmonella Hotspots as Targets for Vaccine Use in Management of Infections in Endemic Settings.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  5. YOUSAFZAI MT, Qamar FN, Shakoor S, Saleem K, et al
    Ceftriaxone-resistant Salmonella Typhi Outbreak in Hyderabad City of Sindh, Pakistan: High Time for the Introduction of Typhoid Conjugate Vaccine.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  6. SAHASTRABUDDHE S, Saluja T
    Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  7. BENTSI-ENCHILL AD, Hombach J
    Revised Global Typhoid Vaccination Policy.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  8. STEELE AD, Parashar UD
    Rotavirus Vaccines set to make inroads in Asia.
    Clin Infect Dis. 2019 Feb 13. pii: 5316811. doi: 10.1093.
    PubMed     Text format    


  9. SCHWARTZ LM, Zaman K, Yunus M, Basunia AH, et al
    Impact of rotavirus vaccine introduction in children less than 2 years of age presenting for medical care with diarrhea in rural Matlab, Bangladesh.
    Clin Infect Dis. 2019 Feb 12. pii: 5316286. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. DESTEFANO F, Bodenstab HM, Offit PA
    Principal Controversies in Vaccine Safety in the United States.
    Clin Infect Dis. 2019 Feb 12. pii: 5316263. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. SEGALOFF HE, Leventer-Roberts M, Riesel D, Malosh RE, et al
    Influenza Vaccine Effectiveness Against Hospitalization in Fully and Partially Vaccinated Children in Israel; 2015-16, 2016-17, and 2017-18.
    Clin Infect Dis. 2019 Feb 11. pii: 5314854. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. SKOWRONSKI DM, De Serres G, Orenstein WA
    Caution required in the use of administrative data and general laboratory submissions for influenza vaccine effectiveness estimation.
    Clin Infect Dis. 2019 Feb 7. pii: 5308623. doi: 10.1093.
    PubMed     Text format    


  13. ROLFES MA, Flannery B, Chung J, O'Halloran A, et al
    Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season.
    Clin Infect Dis. 2019 Feb 2. pii: 5305915. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. NEUZIL KM, Fitzpatrick MC
    The Impact of Influenza Vaccine: It's the Size of the Glass.
    Clin Infect Dis. 2019 Feb 2. pii: 5306034. doi: 10.1093.
    PubMed     Text format    


  15. KOREM M, Orenbuch-Harroch E, Ben-Chetrit E, Israel S, et al
    Intensive care admissions and associated severity of influenza B versus A during influenza B-vaccine mismatched seasons.
    Clin Infect Dis. 2019 Feb 1. pii: 5305596. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2019
  16. HASSO-AGOPSOWICZ M, Ladva CN, Lopman B, Sanderson C, et al
    Global review of the age distribution of rotavirus disease in children aged <5 years before the introduction of rotavirus vaccination.
    Clin Infect Dis. 2019 Jan 28. pii: 5303786. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. DIALLO A, Diop OM, Diop D, Niang MN, et al
    Effectiveness of seasonal influenza vaccination of children in Senegal during a year of vaccine mismatch: a cluster-randomized trial.
    Clin Infect Dis. 2019 Jan 28. pii: 5303780. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. GREENWOOD B
    Sustaining Protection Against Epidemic Meningitis in Africa After Vaccination.
    Clin Infect Dis. 2019;68:444-445.
    PubMed     Text format    


  19. MORDMULLER B, Sulyok M, Egger-Adam D, Resende M, et al
    First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria.
    Clin Infect Dis. 2019 Jan 10. pii: 5281109. doi: 10.1093/cid/ciy1140.
    PubMed     Text format     Abstract available


  20. VEKEMANS J, Gouvea-Reis F, Kim JH, Excler JL, et al
    The path to group A Streptococcus vaccines: WHO research and development technology roadmap and preferred product characteristics.
    Clin Infect Dis. 2019 Jan 8. pii: 5280612. doi: 10.1093/cid/ciy1143.
    PubMed     Text format     Abstract available


  21. ASNER SA, Agyeman PKA, Gradoux E, Posfay-Barbe KM, et al
    Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines - a prospective population-based cohort study.
    Clin Infect Dis. 2019 Jan 2. pii: 5270128. doi: 10.1093/cid/ciy1139.
    PubMed     Text format     Abstract available


    December 2018
  22. HARDER T, Siedler A
    Systematic review and meta-analysis of chickenpox vaccination and risk of herpes zoster: a quantitative view on the "exogenous boosting hypothesis".
    Clin Infect Dis. 2018 Dec 24. pii: 5258112. doi: 10.1093/cid/ciy1099.
    PubMed     Text format     Abstract available


  23. MUJURU HA, Burnett E, Nathoo KJ, Ticklay I, et al
    Monovalent rotavirus vaccine effectiveness against rotavirus hospitalizations among children in Zimbabwe.
    Clin Infect Dis. 2018 Dec 23. pii: 5258061. doi: 10.1093/cid/ciy1096.
    PubMed     Text format     Abstract available


  24. MEHANNA H, Bryant TS, Babrah J, Louie K, et al
    Human papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV16 prevalence in the UK; a cross-sectional study.
    Clin Infect Dis. 2018 Dec 22. pii: 5257796. doi: 10.1093/cid/ciy1081.
    PubMed     Text format     Abstract available


  25. SOENTJENS P, De Koninck K, Tsoumanis A, Herssens N, et al
    A Comparative Immunogenicity and Safety Trial of Two Different Schedules of Single-visit Intradermal Rabies Post-exposure Vaccination Following a Single-visit Pre-exposure Vaccination.
    Clin Infect Dis. 2018 Dec 19. pii: 5253211. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. DEJON-AGOBE JC, Ateba-Ngoa U, Lalremruata A, Homoet A, et al
    Controlled human malaria infection of healthy lifelong malaria-exposed adults to assess safety, immunogenicity and efficacy of the asexual blood stage malaria vaccine candidate GMZ2.
    Clin Infect Dis. 2018 Dec 18. pii: 5252072. doi: 10.1093/cid/ciy1087.
    PubMed     Text format     Abstract available


  27. POLLOCK L, Bennett A, Jere KC, Dube Q, et al
    Non-secretor histo-blood group antigen phenotype is associated with reduced risk of clinical rotavirus vaccine failure in Malawian infants.
    Clin Infect Dis. 2018 Dec 18. pii: 5252030. doi: 10.1093/cid/ciy1067.
    PubMed     Text format     Abstract available


  28. FERDINANDS JM, Patel MM, Foppa IM, Fry AM, et al
    Influenza Vaccine Effectiveness.
    Clin Infect Dis. 2018 Dec 18. pii: 5251717. doi: 10.1093/cid/ciy1084.
    PubMed     Text format    


  29. CHEN H, Alvarez JJS, Ng SH, Nielsen R, et al
    Passage adaptation correlates with the reduced efficacy of the influenza vaccine.
    Clin Infect Dis. 2018 Dec 18. pii: 5252062. doi: 10.1093/cid/ciy1065.
    PubMed     Text format     Abstract available


  30. SEMCHENKO EA, Tan A, Borrow R, Seib KL, et al
    The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae.
    Clin Infect Dis. 2018 Dec 14. pii: 5247042. doi: 10.1093/cid/ciy1061.
    PubMed     Text format     Abstract available


  31. NICHOLS MK, Andrew MK, Ye L, Hatchette TF, et al
    The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness (VE) to Prevent Influenza-Related Hospitalizations over Four Influenza Seasons in Canada.
    Clin Infect Dis. 2018 Dec 3. pii: 5228721. doi: 10.1093/cid/ciy1009.
    PubMed     Text format     Abstract available


    November 2018
  32. HARPAZ R, Leung JW
    The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Children.
    Clin Infect Dis. 2018 Nov 29. pii: 5213086. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. HARPAZ R, Leung JW
    The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Older Adults.
    Clin Infect Dis. 2018 Nov 29. pii: 5213085. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. BRICKLEY EB, Wright PF, Khalenkov A, Neuzil KM, et al
    The effect of pre-existing immunity on virus detection and immune responses in a phase II randomized trial of a Russian-backbone live attenuated influenza vaccine in Bangladeshi children.
    Clin Infect Dis. 2018 Nov 27. pii: 5210472. doi: 10.1093/cid/ciy1004.
    PubMed     Text format     Abstract available


  35. LEWIS KDC, Ortiz JR, Rahman MZ, Levine MZ, et al
    Immunogenicity and viral shedding of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled trial among pre-school aged children in urban Bangladesh.
    Clin Infect Dis. 2018 Nov 27. pii: 5210460. doi: 10.1093/cid/ciy1003.
    PubMed     Text format     Abstract available


  36. MCHUGH L, Marshall HS, Perrett KP, Nolan T, et al
    The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study.
    Clin Infect Dis. 2018 Nov 23. pii: 5202330. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. KOLDITZ M, Schmitt J, Pletz MW, Tesch F, et al
    Impact of the 13-valent pneumococcal conjugate vaccine on incidence of all-cause pneumonia in adults aged >/= 60 years - a population-based retrospective cohort study.
    Clin Infect Dis. 2018 Nov 21. pii: 5194155. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. LOEVINSOHN G, Rosman L, Moss WJ
    Measles Seroprevalence and Vaccine Responses in HIV-Infected Adolescents and Adults: A Systematic Review.
    Clin Infect Dis. 2018 Nov 17. pii: 5188002. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. MUTSAERTS EAML, Nunes MC, van Rijswijk MN, Klipstein-Grobusch K, et al
    Measles immunity at 4.5 years of age following vaccination at 9 and 15-18 months of age among HIV-infected, HIV-exposed-uninfected and HIV-unexposed children.
    Clin Infect Dis. 2018 Nov 12. pii: 5174340. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2018
  40. ALTAMIRANO J, Purington N, Behl R, Sarnquist C, et al
    Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  41. GAENSBAUER JT, Gast C, Bandyopadhyay AS, O'Ryan M, et al
    Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  42. ALTAMIRANO J, Leary S, van Hoorebeke C, Sarnquist C, et al
    Validation of a High-throughput, Multiplex, Real-time Qualitative Polymerase Chain Reaction Assay for the Detection of Sabin Oral Polio Vaccine in Environmental Samples.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  43. VAN HOOREBEKE C, Huang C, Leary S, Holubar M, et al
    Lab Protocol Paper: Use of a High-throughput, Multiplex Reverse-transcription Quantitative Polymerase Chain Reaction Assay for Detection of Sabin Oral Polio Vaccine in Fecal Samples.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  44. BHAUMIK SK, Kulkarni RR, Weldon WC, Silveira ELV, et al
    Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models: Support for at least 2 Doses.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  45. JARVIS CI, Altamirano J, Sarnquist C, Edmunds WJ, et al
    Spatial Analyses of Oral Polio Vaccine Transmission in an Community Vaccinated With Inactivated Polio Vaccine.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  46. RESIK S, Tejeda A, Mach O, Fonseca M, et al
    Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  47. FU R, Altamirano J, Sarnquist CC, Maldonado YA, et al
    Assessing the Risk of Vaccine-derived Outbreaks After Reintroduction of Oral Poliovirus Vaccine in Postcessation Settings.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  48. BRICKLEY EB, Wieland-Alter W, Connor RI, Ackerman ME, et al
    Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine-only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chil
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  49. ALTAMIRANO J, Sarnquist C, Behl R, Garcia-Garcia L, et al
    OPV Vaccination and Shedding Patterns in Mexican and US Children.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  50. SARNQUIST C, Holubar M, Garcia-Garcia L, Ferreyra-Reyes L, et al
    Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  51. HALPERN MS, Altamirano J, Maldonado Y
    Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  52. BANDYOPADHYAY AS, Modlin JF, Wenger J, Gast C, et al
    Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  53. DANINO D, Givon-Lavi N, Ben-Shimol S, Greenberg D, et al
    Understanding the evolution of antibiotic-nonsusceptible pneumococcal nasopharyngeal colonization following pneumococcal conjugate vaccines implementation in young children.
    Clin Infect Dis. 2018 Oct 29. pii: 5146358. doi: 10.1093.
    PubMed     Text format     Abstract available


  54. HAVERS FP, Chung JR, Belongia EA, McLean HQ, et al
    Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017.
    Clin Infect Dis. 2018 Oct 27. pii: 5145968. doi: 10.1093.
    PubMed     Text format     Abstract available


  55. SINGS HL, De Wals P, Gessner BD, Isturiz R, et al
    Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-Analysis of Observational Studies.
    Clin Infect Dis. 2018 Oct 23. pii: 5142858. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. LOPEZ BERNAL JA, Andrews N, Amirthalingam G
    The use of quasi-experimental designs for vaccine evaluation.
    Clin Infect Dis. 2018 Oct 22. pii: 5140188. doi: 10.1093.
    PubMed     Text format     Abstract available


  57. PRAHARAJ I, Platts-Mills JA, Taneja S, Antony K, et al
    Diarrheal etiology and impact of co-infections on rotavirus vaccine efficacy estimates in a clinical trial of a monovalent human-bovine (116E) oral rotavirus vaccine, Rotavac, India.
    Clin Infect Dis. 2018 Oct 17. pii: 5134205. doi: 10.1093.
    PubMed     Text format     Abstract available


  58. SMITS G, Stabell Benn C, Whittle H, van Binnendijk R, et al
    Maternal measles antibodies and their influence on all-cause mortality following measles vaccination: an alternative to measure very low maternal antibody levels.
    Clin Infect Dis. 2018 Oct 16. pii: 5133427. doi: 10.1093.
    PubMed     Text format     Abstract available


  59. WEINBERGER DM, Shapiro ED
    Prevention of Pneumococcal Infections in Adults using Conjugate Vaccines: No Easy Answers.
    Clin Infect Dis. 2018 Oct 12. pii: 5127383. doi: 10.1093.
    PubMed     Text format    


  60. VADLAMUDI NK, Chen A, Marra F
    Impact of 13-pneumococcal conjugate vaccine among adults: a systematic review and meta-analysis.
    Clin Infect Dis. 2018 Oct 12. pii: 5127380. doi: 10.1093.
    PubMed     Text format     Abstract available


  61. HYLE EP, Fields NF, Fiebelkorn AP, Walker AT, et al
    The Clinical Impact and Cost-effectiveness of MMR Vaccination to Prevent Measles Importations among US International Travelers.
    Clin Infect Dis. 2018 Oct 11. pii: 5127132. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Vaccine effectiveness against lineage matched and mismatched influenza B viruses across 8 seasons in Canada, 2010-11 to 2017-18.
    Clin Infect Dis. 2018 Oct 11. pii: 5127119. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. THOMPSON MG, Kwong JC, Regan AK, Katz MA, et al
    Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016.
    Clin Infect Dis. 2018 Oct 11. pii: 5126390. doi: 10.1093.
    PubMed     Text format     Abstract available


  64. MUNOZ FM
    Influenza Vaccination During Pregnancy Can Protect Women Against Hospitalization Across Continents.
    Clin Infect Dis. 2018 Oct 11. pii: 5126392. doi: 10.1093.
    PubMed     Text format    


  65. HILLIER SL, Ferrieri P, Edwards MS, Ewell M, et al
    A Phase II Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide -Tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization with GBS III.
    Clin Infect Dis. 2018 Oct 3. pii: 5114388. doi: 10.1093.
    PubMed     Text format     Abstract available


  66. YOUNG B, Sadarangani S, Sen Yew H, Yung CF, et al
    Six-monthly versus annual influenza vaccination in older adults in the tropics: an observer-blind, active-comparator controlled, randomised superiority trial.
    Clin Infect Dis. 2018 Oct 1. pii: 5113434. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  67. WANG W, Chen Q, Ford-Siltz LA, Katzelnick LC, et al
    Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains after Vaccination with Inactivated Trivalent Influenza Vaccine Vary with Age and Prior Year Vaccination.
    Clin Infect Dis. 2018 Sep 25. pii: 5106972. doi: 10.1093.
    PubMed     Text format     Abstract available


  68. GIBANI MM, Voysey M, Jin C, Jones C, et al
    The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies.
    Clin Infect Dis. 2018 Sep 25. pii: 5106547. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. LEE RU, Phillips CJ, Faix DJ
    Seasonal Influenza Vaccine Impact on Pandemic H1N1 Vaccine Efficacy.
    Clin Infect Dis. 2018 Sep 20. pii: 5104116. doi: 10.1093.
    PubMed     Text format     Abstract available


  70. PINANA JL, Perez A, Montoro J, Gimenez E, et al
    Clinical effectiveness of influenza vaccination after allogeneic hematopoietic stem cell transplantation: A cross-sectional prospective observational study.
    Clin Infect Dis. 2018 Sep 15. pii: 5098399. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. FLANNERY B, Chung JR, Monto AS, Martin ET, et al
    Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season.
    Clin Infect Dis. 2018 Sep 11. pii: 5094815. doi: 10.1093.
    PubMed     Text format     Abstract available


  72. RAY GT, Lewis N, Klein NP, Daley MF, et al
    Intra-season Waning of Influenza Vaccine Effectiveness.
    Clin Infect Dis. 2018 Sep 10. pii: 5094689. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. LIPSITCH M
    Challenges of vaccine effectiveness and waning studies.
    Clin Infect Dis. 2018 Sep 10. pii: 5094713. doi: 10.1093.
    PubMed     Text format    


  74. CHEN LH, Kozarsky PE, Visser LG
    What's old is new again: the re-emergence of yellow fever in Brazil and vaccine shortages.
    Clin Infect Dis. 2018 Sep 10. pii: 5094712. doi: 10.1093.
    PubMed     Text format     Abstract available


  75. COWLING BJ, Lim WW, Perera RAPM, Fang VJ, et al
    Influenza hemagglutination-inhibition antibody titer as a mediator of vaccine-induced protection for influenza B.
    Clin Infect Dis. 2018 Sep 8. pii: 5092748. doi: 10.1093.
    PubMed     Text format     Abstract available


  76. POMAT WS, van den Biggelaar AHJ, Wana S, Greenhill AR, et al
    Safety and immunogenicity of pneumococcal conjugate vaccines in a high-risk population: a randomised controlled trial of 10-valent and 13-valent PCV in Papua New Guinean infants.
    Clin Infect Dis. 2018 Sep 3. pii: 5089945. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2018
  77. USUF E, Bottomley C, Bojang E, Cox I, et al
    Persistence of nasopharyngeal pneumococcal vaccine serotypes and increase of non-vaccine serotypes among vaccinated infants and their mothers five years after PCV13 introduction in The Gambia.
    Clin Infect Dis. 2018 Aug 24. pii: 5079135. doi: 10.1093.
    PubMed     Text format     Abstract available


  78. BLYTH CC, Macartney KK, McRae J, Clark JE, et al
    Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration.
    Clin Infect Dis. 2018 Aug 21. pii: 5077025. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  79. YARO S, Njanpop Lafourcade BM, Ouangraoua S, Ouoba A, et al
    Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?
    Clin Infect Dis. 2018 Jul 26. pii: 5059984. doi: 10.1093.
    PubMed     Text format     Abstract available


  80. BLANCHARD ROHNER G, Chatzis O, Chinwangso P, Rohr M, et al
    Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
    Clin Infect Dis. 2018 Jul 26. pii: 5059783. doi: 10.1093.
    PubMed     Text format     Abstract available


  81. PETOUSIS-HARRIS H, Howe AS, Janine P, Turner N, et al
    Pneumococcal conjugate vaccines turning the tide on inequity - a retrospective cohort study of New Zealand children born 2006-2015.
    Clin Infect Dis. 2018 Jul 19. pii: 5055833. doi: 10.1093.
    PubMed     Text format     Abstract available


  82. BAKER JM, Tate JE, Steiner CA, Haber MJ, et al
    Longer-term direct and indirect effects of infant rotavirus vaccination across all ages in the US; 2000 - 2013: analysis of a large hospital discharge dataset.
    Clin Infect Dis. 2018 Jul 18. pii: 5055445. doi: 10.1093.
    PubMed     Text format     Abstract available


  83. HALPERIN SA, Langley JM, Ye L, MacKinnon-Cameron D, et al
    A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.
    Clin Infect Dis. 2018 Jul 13. pii: 5053576. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. XU Y, Ye J
    Predicting influenza vaccine effectiveness with hemagglutinin sequences is not sufficient enough.
    Clin Infect Dis. 2018 Jul 9. pii: 5050680. doi: 10.1093.
    PubMed     Text format    


  85. MCCLYMONT E, Lee M, Raboud J, Coutlee F, et al
    The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living with HIV.
    Clin Infect Dis. 2018 Jul 7. pii: 5050411. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  86. STEINER-MONARD V, Kamaka K, Karoui O, Roethlisberger S, et al
    The Candidate Blood Stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase I Trial in Exposed and Non Exposed Volunteers.
    Clin Infect Dis. 2018 Jun 26. pii: 5045203. doi: 10.1093.
    PubMed     Text format     Abstract available


  87. SOENTJENS P, Andries P, Aerssens A, Tsoumanis A, et al
    Pre-exposure intradermal rabies vaccination: a non-inferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days.
    Clin Infect Dis. 2018 Jun 25. pii: 5043520. doi: 10.1093.
    PubMed     Text format     Abstract available


  88. TRIEU MC, Jul-Larsen A, Saevik M, Madsen A, et al
    Antibody responses to influenza A/H1N1pdm09 virus after pandemic and seasonal influenza vaccination in healthcare workers: a five-year follow-up study.
    Clin Infect Dis. 2018 Jun 9. pii: 5035295. doi: 10.1093.
    PubMed     Text format     Abstract available


  89. CHERRY JD, Zahn M
    Clinical Characteristics of Measles in Previously Vaccinated and Unvaccinated Patients in California.
    Clin Infect Dis. 2018 Jun 7. pii: 5034094. doi: 10.1093.
    PubMed     Text format     Abstract available


  90. MOSS W
    Measles in Vaccinated Individuals and the Future of Measles Elimination.
    Clin Infect Dis. 2018 Jun 7. pii: 5034071. doi: 10.1093.
    PubMed     Text format    


  91. KILMER GA, Barker LK, Ly KN, Jiles RB, et al
    Hepatitis B vaccination and screening among foreign-born women of reproductive age in the United States: 2013-2015.
    Clin Infect Dis. 2018 Jun 1. pii: 5026244. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  92. SORUP S, Jensen AKG, Aaby P, Benn CS, et al
    Revaccination with Measles-mumps-rubella Vaccine and Infectious Disease Morbidity: A Danish Register-based Cohort Study.
    Clin Infect Dis. 2018 May 26. pii: 5005938. doi: 10.1093.
    PubMed     Text format     Abstract available


  93. MCLAUGHLIN JM, Jiang Q, Isturiz RE, Sings HL, et al
    Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.
    Clin Infect Dis. 2018 May 21. pii: 5000157. doi: 10.1093.
    PubMed     Text format     Abstract available


  94. BURKE RM, Tate JE, Dahl RM, Aliabadi N, et al
    Rotavirus Vaccination Is Associated with Reduced Seizure Hospitalization Risk Among Commercially Insured U.S. Children.
    Clin Infect Dis. 2018 May 16. pii: 4996816. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  95. CASADEVALL A, Pirofski LA
    A Therapeutic Vaccine for Recurrent Vulvovaginal Candidiasis.
    Clin Infect Dis. 2018 Apr 25. pii: 4984538. doi: 10.1093.
    PubMed     Text format    


  96. EDWARDS JE JR, Schwartz MM, Schmidt CS, Sobel JD, et al
    A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial.
    Clin Infect Dis. 2018 Apr 25. pii: 4984537. doi: 10.1093.
    PubMed     Text format     Abstract available


  97. SKOWRONSKI DM, De Serres G
    Role of egg-adaptation mutations in low influenza A(H3N2) vaccine effectiveness during the 2012-13 season.
    Clin Infect Dis. 2018 Apr 24. pii: 4983050. doi: 10.1093.
    PubMed     Text format    


  98. KOSIKOVA M, Li L, Radvak P, Ye Z, et al
    Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications on Seasonal Vaccine Strain Selection and Vaccine Performance.
    Clin Infect Dis. 2018 Apr 17. pii: 4972882. doi: 10.1093.
    PubMed     Text format     Abstract available


  99. BONOMO ME, Deem MW
    Predicting Influenza H3N2 Vaccine Efficacy from Evolution of the Dominant Epitope.
    Clin Infect Dis. 2018 Apr 17. pii: 4972858. doi: 10.1093.
    PubMed     Text format     Abstract available


  100. WILKIN TJ, Chen H, Cespedes MS, Leon-Cruz JT, et al
    A randomized, placebo-controlled trial of the quadrivalent HPV vaccine in HIV-infected adults age 27 years or older: AIDS Clinical Trials Group protocol A5298.
    Clin Infect Dis. 2018 Apr 5. pii: 4961357. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  101. SIGURETHSSON S, Eythorsson E, Hrafnkelsson B, Erlendsdottir H, et al
    Reduction in all-cause acute otitis media in children less than three years of age in primary care following pneumococcal vaccination with PHiD-CV10: A whole population study.
    Clin Infect Dis. 2018 Mar 30. pii: 4956759. doi: 10.1093.
    PubMed     Text format     Abstract available


  102. HANSON KE, Koch B, Bonner K, McRee AL, et al
    National Trends in Parental HPV Vaccination Intentions and Reasons for Hesitancy, 2010-2015.
    Clin Infect Dis. 2018 Mar 27. pii: 4955216. doi: 10.1093.
    PubMed     Text format     Abstract available


  103. BENSON CA, Andersen JW, Macatangay BJC, Mailliard RB, et al
    Safety and Immunogenicity of Zoster Vaccine Live in HIV-Infected Adults with CD4+ Cell Counts Above 200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.
    Clin Infect Dis. 2018 Mar 26. pii: 4953774. doi: 10.1093.
    PubMed     Text format     Abstract available


  104. DE SERRES G, Skowronski DM
    Ecological Fallacy, Nonspecific Outcomes, and the Attribution of Disproportionate Vaccine Benefits.
    Clin Infect Dis. 2018 Mar 21. pii: 4948704. doi: 10.1093.
    PubMed     Text format    


  105. SAITO N, Komori K, Suzuki M, Kishikawa T, et al
    Dose-Dependent Negative Effects of Prior Multiple Vaccinations against Influenza A and Influenza B among School Children: A Study of Kamigoto Island in Japan during the 2011/12, 2012/13 and 2013/14 Influenza Seasons.
    Clin Infect Dis. 2018 Mar 8. pii: 4924693. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  106. COBEY S, Gouma S, Parkhouse K, Chambers BS, et al
    Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012-13.
    Clin Infect Dis. 2018 Feb 20. pii: 4846904. doi: 10.1093.
    PubMed     Text format     Abstract available


  107. ANDERSON EJ, Daugherty MA, Pickering LK, Orenstein WA, et al
    Protecting the Community through Child Vaccination.
    Clin Infect Dis. 2018 Feb 17. pii: 4868144. doi: 10.1093.
    PubMed     Text format     Abstract available


  108. JAYASINGHE S, Chiu C, Quinn H, Menzies R, et al
    Effectiveness of Seven and Thirteen Valent Pneumococcal Conjugate Vaccines in a Schedule without a Booster dose: a Ten Year Observational Study.
    Clin Infect Dis. 2018 Feb 17. pii: 4868133. doi: 10.1093.
    PubMed     Text format     Abstract available



  109. Philippines Says Anti-Dengue Vaccine may be Connected to Three Deaths.
    Clin Infect Dis. 2018 Feb 17. pii: 4868143. doi: 10.1093.
    PubMed     Text format    


  110. WHITNEY CG
    Examining Duration of Protection: should a Booster dose be Part of all Infant Pneumococcal Conjugate Vaccine Programs?
    Clin Infect Dis. 2018 Feb 17. pii: 4868134. doi: 10.1093.
    PubMed     Text format    


  111. KATZ J, Englund JA, Steinhoff MC, Khatry SK, et al
    Impact of timing of influenza vaccination in pregnancy on transplacental antibody transfer, influenza incidence and birth outcomes; a randomized trial in rural Nepal.
    Clin Infect Dis. 2018 Feb 14. pii: 4857181. doi: 10.1093.
    PubMed     Text format     Abstract available


  112. IZURIETA HS, Chillarige Y, Kelman JA, Forshee R, et al
    Statin use and risks of influenza-related outcomes among older adults receiving standard-dose or high-dose influenza vaccines through Medicare during 2010-2015.
    Clin Infect Dis. 2018 Feb 9. pii: 4846330. doi: 10.1093.
    PubMed     Text format     Abstract available


  113. SUZUKI M, Saito N
    Influenza vaccine effectiveness and age.
    Clin Infect Dis. 2018 Feb 7. pii: 4841718. doi: 10.1093.
    PubMed     Text format    


    January 2018
  114. VOYSEY M, Pollard AJ
    Sero-efficacy of Vi-polysaccharide tetanus-toxoid typhoid conjugate vaccine (Typbar-TCV).
    Clin Infect Dis. 2018 Jan 17. pii: 4815743. doi: 10.1093/cid/cix1145.
    PubMed     Text format     Abstract available


  115. BURGNER DP, Miller JE, Strunk T, Nassar N, et al
    Growth Parameters, Effect Measure Modification and the Association Between Vaccination and Early Childhood Hospitalization With Non-targeted Infections.
    Clin Infect Dis. 2018;66:318-319.
    PubMed     Text format    


  116. VAN DEURSEN AMM, van Houten MA, Webber C, Patton M, et al
    The impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study.
    Clin Infect Dis. 2018 Jan 6. pii: 4792029. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  117. SIMMONS G, Stone M, Busch MP
    Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus Vaccination and Zika Virus Epidemics.
    Clin Infect Dis. 2017 Dec 30. pii: 4760439. doi: 10.1093.
    PubMed     Text format    


  118. PLENNEVAUX E, Moureau A, Arredondo-Garcia JL, Villar L, et al
    Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials.
    Clin Infect Dis. 2017 Dec 30. pii: 4782289. doi: 10.1093.
    PubMed     Text format     Abstract available


  119. CHONG PP, Handler L, Weber DJ
    A Systematic Review of Safety and Immunogenicity of Influenza Vaccination Strategies in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2017 Dec 14. pii: 4743238. doi: 10.1093/cid/cix1081.
    PubMed     Text format     Abstract available


  120. NATORI Y, Shiotsuka M, Slomovic J, Hoschler K, et al
    A Double Blind Randomized Trial of High Dose vs. Standard Dose Influenza Vaccine in Adult Solid Organ Transplant Recipients.
    Clin Infect Dis. 2017 Dec 14. pii: 4743251. doi: 10.1093/cid/cix1082.
    PubMed     Text format     Abstract available


    November 2017
  121. LOPEZ AL, Deen J, Azman AS, Luquero FJ, et al
    Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and meta-analysis.
    Clin Infect Dis. 2017 Nov 21. pii: 4645296. doi: 10.1093/cid/cix1039.
    PubMed     Text format     Abstract available


  122. FISKER AB, Nebie E, Schoeps A, Martins C, et al
    A two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels.
    Clin Infect Dis. 2017 Nov 21. pii: 4645294. doi: 10.1093/cid/cix1033.
    PubMed     Text format     Abstract available


  123. YE S, Whiley DM, Ware RS, Kirkwood CD, et al
    Multivalent rotavirus vaccine and wild-type rotavirus strain shedding in Australian infants: a birth cohort study.
    Clin Infect Dis. 2017 Nov 15. doi: 10.1093/cid/cix1022.
    PubMed     Text format     Abstract available


  124. STEIN Y, Mandelboim M, Sefty H, Pando R, et al
    Seasonal influenza vaccine effectiveness in preventing laboratory-confirmed influenza in primary care in Israel 2016-2017 season: insights into novel age-specific analysis.
    Clin Infect Dis. 2017 Nov 14. doi: 10.1093/cid/cix1013.
    PubMed     Text format     Abstract available


  125. VEIT O, Domingo C, Niedrig M, Staehelin C, et al
    Long-term immune response to yellow fever vaccination in HIV-infected individuals depends on HIV-RNA suppression status: Implications for vaccination schedule.
    Clin Infect Dis. 2017 Nov 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  126. LAWN JE, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, et al
    Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates?
    Clin Infect Dis. 2017;65.
    PubMed     Text format     Abstract available


    October 2017
  127. FATHIMA P, Blyth CC, Lehmann D, Lim FJ, et al
    The impact of pneumococcal vaccination on bacterial and viral pneumonia in Western Australian children: record linkage cohort study of 469,589 births (1996-2012).
    Clin Infect Dis. 2017 Oct 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  128. TAM YH, Valkenburg SA, Perera RAPM, Wong JHF, et al
    Immune responses to twice-annual influenza vaccination in older adults in Hong Kong.
    Clin Infect Dis. 2017 Oct 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  129. POEHLING KA, Caspard H, Peters TR, Belongia EA, et al
    2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  130. ORTIZ JR
    The challenge of vaccine policy-making with imperfect data.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format    


  131. KJAER SK, Nygard M, Dillner J, Brooke Marshall J, et al
    A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries.
    Clin Infect Dis. 2017 Oct 1. doi: 10.1093.
    PubMed     Text format     Abstract available


  132. EBERHARDSON M, Hall S, Papp KA, Sterling TM, et al
    Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Clin Infect Dis. 2017;65:1174-1182.
    PubMed     Text format     Abstract available


  133. OLIGBU G, Collins S, Andrews N, Sheppard CL, et al
    Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.
    Clin Infect Dis. 2017;65:1191-1198.
    PubMed     Text format     Abstract available


    September 2017
  134. SKOFF TH, Blain AE, Watt J, Scherzinger K, et al
    Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.
    Clin Infect Dis. 2017 Sep 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  135. LUCA DL, Kwong JC, Chu A, Sander B, et al
    Impact of Pneumococcal Vaccination on Pneumonia Hospitalizations and Related Costs in Ontario: A Population-Based Ecological Study.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  136. NEMES E, Hesseling AC, Tameris M, Mauff K, et al
    Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  137. MADHI SA, Koen A, Cutland CL, Jose L, et al
    Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.
    Clin Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  138. ARCIUOLO RJ, Jablonski RR, Zucker JR, Rosen JB, et al
    Effectiveness of Measles Vaccination and Immune Globulin Post-Exposure Prophylaxis in an Outbreak Setting-New York City, 2013.
    Clin Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  139. SCHROEDER MR, Chancey ST, Thomas S, Kuo WH, et al
    A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance
    Clin Infect Dis. 2017;65:990-998.
    PubMed     Text format     Abstract available


  140. KIM L, Rha B, Abramson JS, Anderson LJ, et al
    Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines.
    Clin Infect Dis. 2017;65:1020-1025.
    PubMed     Text format     Abstract available


  141. PIROTH L, Launay O, Miailhes P, Carrat F, et al
    Isolated anti-HBc serological profile: has the time come to vaccinate?
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format    


  142. MCNAMARA LA, Skoff T, Faulkner A, Miller L, et al
    Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination-United States, 2010-2012.
    Clin Infect Dis. 2017;65:811-818.
    PubMed     Text format     Abstract available


  143. VAN DEURSEN AMM, van Houten MA, Webber C, Patton M, et al
    Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
    Clin Infect Dis. 2017;65:787-795.
    PubMed     Text format     Abstract available


  144. PILLSBURY AJ, Quinn HE, Evans TD, McIntyre PB, et al
    Population-Level Herd Protection of Males From a Female Human Papillomavirus Vaccination Program: Evidence from Australian Serosurveillance.
    Clin Infect Dis. 2017;65:827-832.
    PubMed     Text format     Abstract available


    August 2017
  145. YANG Y, Meng Y, Halloran ME, Longini IM Jr, et al
    Dependency of Vaccine Efficacy on Pre-Exposure and Age: A Closer Look at a Tetravalent Dengue Vaccine.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  146. LEE YJ, Huang YT, Kim SJ, Kerpelev M, et al
    Trends in invasive pneumococcal disease (IPD) in cancer patients after the introduction of 7-valent pneumococcal conjugate vaccine (PCV7): A 20-year longitudinal study at a major urban cancer center.
    Clin Infect Dis. 2017 Aug 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  147. SHAH M, Quinlisk P, Weigel A, Riley J, et al
    Mumps outbreak in a highly vaccinated university-affiliated setting before and after a measles-mumps-rubella (MMR) vaccination campaign-Iowa, July 2015-May 2016.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  148. HEATH G, Depledge DP, Brown JR, Hale AD, et al
    Acute Retinal Necrosis caused by the zoster vaccine virus.
    Clin Infect Dis. 2017 Aug 2. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  149. LEWNARD JA, Givon-Lavi N, Weinberger DM, Lipsitch M, et al
    Pan-serotype reduction in progression of Streptococcus pneumoniae to otitis media after rollout of pneumococcal conjugate vaccines.
    Clin Infect Dis. 2017 Jul 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  150. WARREN JL, Shioda K, Kurum E, Schuck-Paim C, et al
    Impact of Pneumococcal Conjugate Vaccines on Pneumonia Hospitalizations in High- and Low-Income Subpopulations in Brazil.
    Clin Infect Dis. 2017 Jul 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  151. PETRIE JG, Malosh RE, Cheng CK, Ohmit SE, et al
    The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  152. DE WALS P, Deceuninck G, Lefebvre B, Tsang R, et al
    Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.
    Clin Infect Dis. 2017;64:1263-1267.
    PubMed     Text format     Abstract available


    December 2016
  153. LARSON HJ
    Japanese media and the HPV vaccine saga.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  154. GILL CJ, Mwananyanda L, MacLeod W, Kwenda G, et al
    Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


    June 2016
  155. TRAN TT
    Hepatitis B in Pregnancy.
    Clin Infect Dis. 2016;62 Suppl 4:S314-7.
    PubMed     Text format     Abstract available


  156. SHANKAR H, Blanas D, Bichoupan K, Ndiaye D, et al
    A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants.
    Clin Infect Dis. 2016;62 Suppl 4:S289-97.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: